Cancer Research Horizons Investor
We are a specialist drug discovery, development and commercialisation company, taking cutting edge innovations from the lab bench to the bedside, translating them into effective treatments and diagnostics for cancer patients.
Headquarters:
2 Redman Place, London
Founded Date:
2002-01-01
Investor Type:
Venture Capital
Investors Number:
3
Estimated Revenue:
$1M to $10M